Cancer of the Bladder: Clinical Trials

4 trials for Cancer of the Bladder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1
Phase 31Terminated 1

Follow Cancer of the Bladder: new trials by email Literature Review of Cancer of the Bladder trials Research Report on Cancer of the Bladder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies
Metastatic Urothelial Carcinoma, Urothelial Cancer
Not yet recruitingPfizer51222026-10-212026-10-27
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.
Synergo® RITE + MMC - Bladder Cancer, Bladder Neoplasm
Phase 3TerminatedMedical Enterprises Ltd.52019-04-042020-04-15
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
NanoDoce (direct injection), NanoDoce (intravesical instillation) - Visit 2 Instillation, Institutional Standard of Care - Bladder Cancer, Urothelial Carcinoma
Phase 1 / Phase 2CompletedNanOlogy, LLC362019-04-022023-08-14
The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study
Cardiovascular Diseases, Chronic Obstructive Pulmonary Diseases
UnknownUniversità degli Studi 'G. d'Annunzio' Chieti e Pescara10502013-10-012017-05-05

Narrower conditions

Urinary Bladder Neoplasms (4)  ·  Carcinoma, Transitional Cell (2)  ·  Cardiovascular Diseases (1)  ·  Cigarette Smoking (1)  ·  Disease (1)  ·  Lung Neoplasms (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Stomach Neoplasms (1)  ·  Urogenital Neoplasms (1)  ·  Urologic Neoplasms (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Male Urogenital Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Urinary Bladder Diseases (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Urogenital Neoplasms (3)  ·  Urologic Neoplasms (3)  ·  Carcinoma (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Administration, Intravesical (1)  ·  Docetaxel (1)  ·  Mitomycin (1)  ·  Neoadjuvant Therapy (1)

Sponsors

Medical Enterprises Ltd. (1)  ·  NanOlogy, LLC (1)  ·  Pfizer (1)  ·  Università degli Studi 'G. d'Annunzio' Chieti e Pescara (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

Donald Lamm, MD, FACS (1)  ·  Lamberto Manzoli, MD, MPH (1)  ·  Michael A O'Donnell, MD (1)

Results publications

PMID 26061661, PMID 27272748